Back to search

Switzerland· 33354010

Limbitrol, Hartkapsel

A amitriptylin und psycholeptika product containing amitriptylinum, chlordiazepoxidum, registered in Switzerland by MEDA Pharmaceuticals Switzerland GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 2 of our 19 countries.

Cat B (Swissmedic)ATC N06CA01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedLimbitrol, HartkapselATCN06CA01REGISTER NO.33354010PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Amitriptylin und psycholeptika is registered in 2 of 19 countries.

Countries holding a registration under ATC N06CA01 (amitriptylin und psycholeptika), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 2 of them publish a price we can compare per daily dose

Amitriptylin und psycholeptika · ATC N06CA01

2 / 19 countries

  • Finlandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
amitriptylinum, chlordiazepoxidum
Manufacturer
MEDA Pharmaceuticals Switzerland GmbH
Country
Switzerland (CH)
ATC code
N06CA01
ATC class
Amitriptylin und Psycholeptika
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for amitriptylin und psycholeptika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Amitriptylin und psycholeptika · interactions on record

7 records

7 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Amitriptylin und psycholeptika in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amitriptylin und psycholeptika products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Finland · Klotriptyl, Klotriptyl Mite
  • Italy · Limbitryl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6d98f88c-0c47-4a27-9113-53c985b225c8
GET /v1/drugs/6d98f88c-0c47-4a27-9113-53c985b225c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about amitriptylin und psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.